Hip replacement with the collarless Actis stem in adults with hip damage
Follows adults having hip replacement with the collarless Actis stem for 5 years.
Key facts
- Who runs it
- Seoul National University Bundang Hospital
- Where
- Seongnam-si, South KoreaSee the site
- Trial code
- Registry title
- Clinical Outcomes of Primary Cementless Total Hip Arthroplasty Using the Collarless Actis Stem
- Status
- Recruiting
- People taking part
- 210 people, planned
- Started
- 18 Jun 2025
- Expected to end
- 31 Dec 2031
- Type of study
- Interventional
- Treatments tested
- Collarless Actis femoral stem
- Record updated
- 18 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults already scheduled for a first total hip replacement because of hip arthritis, damaged hip bone or a broken hip. All get the same implant.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Planned first total hip replacement for hip osteoarthritis, developmental dysplasia of the hip, rheumatoid arthritis, non-rheumatoid inflammatory arthritis, post-traumatic arthritis, osteonecrosis of the femoral head, or displaced femoral neck fracture
Main reasons for not taking part
- Under 18 years of age
- Hip replacement done with a femoral stem other than the collarless Actis stem
- Severe medical illness that prevents taking part
- Unwilling to take part in the study
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age 18 years or older
- Scheduled to undergo primary total hip arthroplasty for one of the following: osteoarthritis of the hip, developmental dysplasia of the hip, rheumatoid arthritis, non-rheumatoid inflammatory arthritis, post-traumatic arthritis, osteonecrosis of the femoral head, or displaced femoral neck fracture
- Willing and able to provide written informed consent
Who cannot take part
- Age under 18 years
- Total hip arthroplasty performed with a femoral stem other than the collarless Actis stem
- Severe medical comorbidity precluding participation
- Unwilling to participate in the study
Where in South Korea
- Seoul National University Bundang HospitalSeongnam-si, South KoreaContact: Jung-Wee Park, MDTaking people
About the trial
What the trial wants to find out
This study looks at how well a hip replacement using the collarless Actis stem works over five years.
Read full original descriptionShow less
Total hip replacement is a common operation for people whose hip joint has been damaged by arthritis, by loss of blood supply to the hip bone, or by a broken hip. During the operation, the damaged parts of the hip are replaced with artificial parts. The Actis stem is the part that is fitted into the thigh bone. It is designed to bond directly with the bone, without the use of bone cement.
The Actis stem is already used in many countries, and early results have been good. However, almost all of those results come from Western patients, and most studies used a version of the stem that has a small collar. Very little is known about how the collarless version performs in Asian patients, who tend to be younger at the time of surgery and more often have the operation because of loss of blood supply to the hip bone.
People aged 18 years or older who are already scheduled for a hip replacement at this hospital may take part. Everyone who takes part has the same operation, with the same set of artificial parts. No extra tests are done for research purposes.
After surgery, participants return to the clinic at 6 weeks, 3 months, and 12 months, and then once a year until 5 years have passed. These are the same visits that patients would have anyway. At each visit, the study team checks for any problems with the new hip, takes routine X-rays, and asks participants to fill in questionnaires about their hip pain, their daily activities, and their overall health.
The main question the study asks is how many participants have a problem with the new hip within five years, such as the hip coming out of place, an infection, a break in the bone around the implant, or the implant becoming loose.
The group in the trial
- ActisTreatment being tested
Participants undergo primary cementless total hip arthroplasty using the collarless Actis femoral stem with a Pinnacle acetabular cup and a fourth-generation ceramic-on-ceramic bearing, performed through a posterior approach with the patient in the lateral decubitus position.
Treatment: Collarless Actis femoral stem
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective Cohort Study of Primary Cementless Total Hip Arthroplasty Using Actis Stems
- Plain-language title
- Hip replacement with the collarless Actis stem in adults with hip damageGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 18 September 2026